Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 12.75 Contact Hours.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org

Qualified by the American Board of Radiology on June 26, 2019 in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo, Inc., Eisai, Genentech, Inc., Genomic Health, Inc., Lilly, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer, Puma Biotechnology, Inc., and Seattle Genetics, Inc.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

18th Annual International Congress on the Future of Breast Cancer® West

18th Annual International Congress on the Future of Breast Cancer® West


July 26-27, 2019
The Westin San Diego Gaslamp Quarter

910 Broadway Circle
San Diego, CA 92101
Phone: (619) 239-2200

Overview

The 18th Annual International Congress on the Future of Breast Cancer® West serves as an update on advances in the breast cancer field, with a focus on the clinical implications of breast cancer genetic and phenotypic subtyping. Novel agents, strategies, and improved regimens are changing the future of breast cancer therapy, and these advances and their clinical impact are highlighted throughout the program. Current controversies in the field are also addressed and debated and new data presented, along with information about how to optimally individualize breast cancer therapy. This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other healthcare professionals to learn from and interact with international leaders in the field of breast cancer in order to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo, Inc., Eisai, Genentech, Inc., Genomic Health, Inc., Lilly, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer, Puma Biotechnology, Inc., and Seattle Genetics, Inc.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Learning Objectives

  • Individualize treatment planning for patients with breast cancer, integrating biomarker results and molecular and/or genomic assays as appropriate
  • Review the latest advances and best practices in surgery and radiation therapy in order to optimize locoregional control in patients with early-stage or locally advanced breast cancer
  • Integrate recent clinical trial results with systemic agents into personalized treatment strategies to optimize outcomes for patients with breast cancer
  • Discuss the impact of emerging data regarding investigational approaches on evolving treatment paradigms for managing breast cancer
  • Identify variances in care and planned/ongoing clinical trials that are evaluating investigational approaches in breast cancer treatment settings

Program Co-Chairs

Sara Hurvitz
Sara Hurvitz, MD
Director, Breast Cancer Clinical Research Program
Co-Director, Santa Monica – UCLA Outpatient Hematology/Oncology Practice
Associate Professor of Medicine, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Santa Monica, CA
 
Joyce O'Shaughnessy
Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
Co-Chair, Breast Cancer Research Program,
The US Oncology Network
Dallas, TX

Registration

Physicians' Education Resource - IBW19
2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Registration Fees
  Advanced Onsite
Physicians $299 $349
Fellows* $199 $249
Nurses, PAs, Other Health Care Professionals $129 $179
Industry** $499 $599
 
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.

**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
 
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to June 19, 2019, and a 50% fee on refunds requested on June 18, 2019, through July 18, 2019. No refunds will be made after July 18, 2019. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image").  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
2930
Filter By